coin-img-ETHETH+0.58%coin-img-SOLSOL+0.35%coin-img-BTCBTC+1.04%coin-img-USDCUSDC+0.01%coin-img-XRPXRP+1.36%coin-img-NEARNEAR+10.87%coin-img-DOGEDOGE+2.19%coin-img-SUISUI+3.16%coin-img-ETHETH+0.58%coin-img-SOLSOL+0.35%coin-img-BTCBTC+1.04%coin-img-USDCUSDC+0.01%coin-img-XRPXRP+1.36%coin-img-NEARNEAR+10.87%coin-img-DOGEDOGE+2.19%coin-img-SUISUI+3.16%coin-img-ETHETH+0.58%coin-img-SOLSOL+0.35%coin-img-BTCBTC+1.04%coin-img-USDCUSDC+0.01%coin-img-XRPXRP+1.36%coin-img-NEARNEAR+10.87%coin-img-DOGEDOGE+2.19%coin-img-SUISUI+3.16%coin-img-ETHETH+0.58%coin-img-SOLSOL+0.35%coin-img-BTCBTC+1.04%coin-img-USDCUSDC+0.01%coin-img-XRPXRP+1.36%coin-img-NEARNEAR+10.87%coin-img-DOGEDOGE+2.19%coin-img-SUISUI+3.16%
user-avatar
Markets Insider

Humana shares jump about 12% after CMS data show stronger 2027 Star Ratings; Baird upgrades to Buy

AI Market Summary
CMS' 2027 Star Ratings show a sharp improvement for Humana's Medicare Advantage and Part D plans, lifting eligibility for quality bonus payments and improving perceived earnings durability. With 95% of MA members in 4+ star plans and expanded 4.5-star coverage, analysts upgraded the stock and raised targets, highlighting better margins and a clearer path to profit recovery versus peers facing rating pressure.
Impact level
● Medium
Affected assets
NCSKHUM2USD/USDT-3.54%
AI Insight · NCSKHUM2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Federal CMS data for 2027 showed a sharp improvement in Humana’s Star Ratings, with 95% of its Medicare Advantage members in plans rated 4.0 stars or higher and 42% in 4.5-star plans. Humana shares rose about 12% intraday following the update. Baird upgraded the stock to Buy from Hold and lifted its price target to $596 from $390, citing confidence in 2028 adjusted EPS of more than $35.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.